NCT01456546View on ClinicalTrials.gov

Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
CYP2C19 Genotypes
Interventions
DRUG

Proguanil

2x350 mg Malarone followed by 3 days of blood- and urine sampling

DRUG

Clopidogrel

2x300 mg Plavix followed by 7 hours days of blood sampling

Trial Locations (1)

DK-5000

Clinical Pharmacology, University of Southern Denmark, Odense

All Listed Sponsors
lead

University of Southern Denmark

OTHER

NCT01456546 - Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel | Biotech Hunter | Biotech Hunter